|
RBM12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.03639999810201E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.65309999969432E-07 |
| Normal-vs-Stage2 |
1.03870000045525E-07 |
| Normal-vs-Stage3 |
2.44469999799435E-08 |
| Normal-vs-Stage4 |
2.58389976082185E-10 |
| Stage1-vs-Stage2 |
1.766170E-01 |
| Stage1-vs-Stage3 |
1.723650E-01 |
| Stage1-vs-Stage4 |
9.354000E-04 |
| Stage2-vs-Stage3 |
7.275400E-01 |
| Stage2-vs-Stage4 |
3.330000E-01 |
| Stage3-vs-Stage4 |
8.915800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.67730000181166E-08 |
| Normal-vs-AfricanAmerican |
2.839000E-03 |
| Normal-vs-Asian |
1.50060000003727E-06 |
| Caucasian-vs-AfricanAmerican |
3.048800E-01 |
| Caucasian-vs-Asian |
9.516400E-01 |
| AfricanAmerican-vs-Asian |
3.714000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.62639995810099E-09 |
| Normal-vs-Female |
9.93050000008822E-08 |
| Male-vs-Female |
6.145800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.14799999995085E-06 |
| Normal-vs-Age(41-60Yrs) |
9.82710002261911E-09 |
| Normal-vs-Age(61-80Yrs) |
5.82399994897287E-09 |
| Normal-vs-Age(81-100Yrs) |
3.319900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.945600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.963800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.902200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.610400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.112000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.829200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.548100E-02 |
| Classical-VS-Follicular |
4.25069999999694E-05 |
| Classical-VS-Other |
4.078100E-02 |
| Classical-VS-Normal |
1.70290000001128E-06 |
| Tall-VS-Follicular |
3.360000E-01 |
| Tall-VS-Other |
2.025400E-01 |
| Tall-VS-Normal |
8.61129999529808E-08 |
| Follicular-VS-Other |
5.391000E-01 |
| Follicular-VS-Normal |
5.87530024631633E-10 |
| Other-VS-Normal |
1.277250E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.42359995697939E-09 |
| Normal-vs-N1 |
1.77519999811082E-08 |
| N0-vs-N1 |
5.392200E-01 |
|
|
